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A protocol for the ab initio crystal structure determination of powdered solids at natural 
isotopic abundance by combining solid-state NMR spectroscopy, crystal structure 
prediction, and DFT chemical shift calculations was evaluated to determine the crystal 
structures of four small drug molecules: cocaine, flutamide, flufenamic acid, and 
theophylline. For cocaine, flutamide and flufenamic acid, we find that the assigned 1H 
isotropic chemical shifts provide sufficient discrimination to determine the correct 
structures from a set of predicted structures using the root-mean-square deviation 
(rmsd) between experimentally determined and calculated chemical shifts. In most 
cases unassigned shifts could not be used to determine the structures. This method 
requires no prior knowledge of the crystal structure, and was used to determine the 
correct crystal structure to within an atomic rmsd of less than 0.12 Å with respect to 
the known reference structure. For theophylline, the NMR spectra are too simple 
to allow for unambiguous structure selection. 
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1. Introduction 
 Structural characterization remains one of the key 
challenges for modern chemistry. Single crystal diffraction 
methods are capable of characterizing systems as diverse as 
membrane proteins, whole virus particles, or complex 
inorganic materials. In contrast, if the sample is a powder, 
structural characterization represents an enormous challenge 
and other methods of characterizing powdered solids are 
required. 
 In this respect solid-state NMR holds great promise, and 
several approaches can be envisaged. For example, if the 
sample can be isotopically labelled using methods available 
for biological systems, the structure can then be obtained from 
dipolar recoupling or spin diffusion measurements. For small 
molecules, however, an approach based on the analysis of 
chemical shifts would be most attractive. There are today 
many examples of chemical shifts being combined with 
density functional theory (DFT) calculations for structure 
validation in organic molecular compounds with respect to 
known structures1-17. However, there are very few examples of 
ab initio structure determination from powders by NMR 
without a structural hypothesis.  
 The development of computational methods for crystal 
structure prediction (CSP) has been based predominantly on 
global lattice energy minimisation, applying various methods 
for locating low energy structures on the crystal energy 
landscape described by some model of the interactions 
between atoms or molecules. The scope of these methods has 
improved in recent years, providing the ability to predict 
possible stable phases of a wide range of materials. For 
example, these methods have been used for the successful 
prediction of single18-22 and multicomponent19,23-26 organic 
molecular crystals27-30, high-pressure phases of materials31-33, 
and other crystalline network structures such as zeolites or 
carbon polymorphs34-36. Progress in this field for organic 
molecular crystals is regularly assessed in a series of blind 
tests of structure prediction37. 
 Recently, we introduced a method for ab initio natural 
abundance powder NMR crystallography by combining measured 
NMR chemical shifts and computational structure prediction.38 
The method has so far only been illustrated on a single example, 
the small molecule thymol. Here, we investigate the feasibility 
and limitations of this method with four examples of 
pharmacologically relevant substances: cocaine39, a dopamine 
uptake inhibitor drug used in anaesthetics; flutamide40, a non-
steroidal androgen antagonist used for the treatment of prostate 
cancer; flufenamic acid41, a non-steroidal anti-inflammatory drug; 
and theophylline42, a drug used for the treatment of asthma. We 
find that this method works well to identify the correct 
structure from the list of low energy structures generated by 
CSP methodologies, provided that there are a sufficient 
number of assigned experimental NMR resonances. We 
successfully determine the correct structure of cocaine, 
flutamide and flufenamic acid based on the root-mean-square 
deviation (rmsd) resulting from the comparison of 
experimental and DFT calculated 1H chemical shifts. 
However, in the case of theophylline the 1H NMR spectrum is 
too simple for the method to unambiguously identify the 
correct structure based on comparing observed and calculated 
chemical shifts.  
 
2. Experimental 
2a Samples 
 Powdered free base cocaine (methyl(1R,2R,3S,5S)-3- 
(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-
carboxylate) was purchased from Sigma-Aldrich and used 
without further purification. The reference crystal structure of 
cocaine, (CSD entry code: COCAIN10) (Scheme 1-I), was 
previously determined by single crystal X-ray diffraction 
(XRD)39 at room temperature. The structure is comprised of 2 
symmetry equivalent molecules in the unit cell, and it belongs 
to the P21 monoclinic space group with unit cell dimensions: 
a = 10.130(1) Å, b = 9.866(2) Å, c = 8.445(1) Å. 
 Powdered flutamide (2-methyl-N(4-nitro-3-
(trifluoromethyl)phenyl)propamide) was purchased from 
Sigma-Aldrich and used without further purification. The 
reference crystal structure of flutamide, (CSD entry code: 
WEZCOT) (Scheme 1-II), was previously determined by 
single crystal XRD40 at 294 K. The structure is comprised of 4 
symmetry equivalent molecules in the unit cell, and it belongs 
to the Pna21 orthorhombic space group with unit cell 
dimensions: a = 11.856(2) Å, b = 20.477(3) Å, c = 4.9590(9) 
Å. 
 Powdered flufenamic acid (2-((3-
(trifluoromethyl)phenyl)amino)-benzoic acid) was purchased 
from Fluka and used without further purification. The 
reference crystal structure of the corresponding flufenamic 
acid polymorph, (CSD entry code: FPAMCA11) (Scheme 1-
III), was previously determined from single crystal XRD 
data41 recorded at room temperature, and was confirmed by 
powder XRD to be the polymorph studied here. The structure 
comprises 4 symmetry equivalent molecules in the unit cell, 
and it belongs to the P21/c monoclinic space group with unit 
cell dimensions: a = 12.523(4) Å, b = 7.868(6) Å, c = 
12.874(3) Å, and angle  = 95.2(2)°. 
 Powdered theophylline (3,7-dihydro-1,3-dimethyl-1H-
purine-2,6-dione) was purchased from Acros Organics and 
used without further purification. The polymorphic form was 
confirmed to be the most stable orthorhombic polymorph by 
Ebisuzaki et al.42. The reference crystal structure of 
theophylline (CSD entry code: BAPLOT01) (Scheme 1-IV) 
was previously determined42 from single crystal X-ray 
diffraction at room temperature. The structure comprises 4 
symmetry equivalent molecules in the unit cell, and it belongs 
to the Pna21 orthorhombic space group with unit cell 
dimensions: a = 24.612(2) Å, b = 3.8302(4) Å, c = 8.5010(5) 
Å. 
 For each sample the crystals were carefully ground to give 
a fine homogeneous (microcrystalline) powder before 
performing the NMR experiments. 
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Scheme 1 Molecular structure of cocaine (I), flutamide (II), flufenamic 
acid (III) and theophylline (IV) and the labelling scheme used here. 
  
2b NMR experiments 
All NMR experiments were performed at a nominal 
temperature of 293 K with a Bruker Avance III spectrometer 
operating at 1H and 13C Larmor frequencies of 500 MHz and 
125 MHz, respectively. 1D 1H MAS spectra were recorded 
with a 1.3 mm double resonance probe with 60 kHz magic 
angle spinning (MAS). 1D 13C cross-polarisation MAS 
(CPMAS) NMR spectra were recorded with 4 mm double or 
triple resonance probes at 12.5 kHz MAS. 1H chemical shifts 
were referenced to the single resonance observed for protons 
in adamantane at 1.87 ppm with respect to the signal for neat 
TMS. 13C chemical shifts were referenced to the CH2 
resonance observed for adamantane at 38.48 ppm with respect 
to the signal for neat TMS43. 
 The 2D refocused 13C-13C INADEQUATE44 NMR spectra 
were recorded with a 4 mm triple resonance probe at 12.5 kHz 
MAS. The SPINAL-6445 sequence at a proton nutation 
frequency 1 of 80 kHz was used for heteronuclear 
decoupling. 256 increments of 512 transients each were 
acquired with a repetition delay of 4.5 s, resulting in a total 
experimental time of 7 days for cocaine. 64 increments of 
1024 transients each were acquired with a repetition delay of 
4 s, resulting in a total experimental time of 3 days for 
flutamide. The delay in the echo blocks was  = 4 ms. The 
acquisition time was set to 22 ms in t2, and the maximum t1 
delay was t1
max = 2.6 ms. Exponential line broadening of 70 
Hz was applied in the direct and indirect dimensions prior to 
the Fourier transform. 
 The 2D refocused 1H-13C INEPT46 NMR spectra were 
recorded with a 4 mm double resonance probe at 12.5 kHz 
MAS. The SPINAL-6445 sequence at a proton 1 of 100 kHz 
was used for heteronuclear decoupling. The eDUMBO-122
47 
sequence at a nutation frequency of 100 kHz was used for 
proton homonuclear decoupling in the indirect dimension. The 
1H axis has been corrected for the experimentally determined 
homonuclear decoupling scaling factor using a value of 0.6. 
For cocaine 128 increments of 256 transients each were 
acquired with a repetition delay of 8 s, resulting in a total 
experimental time of 3 days. For flutamide 200 increments of 
16 transients each were acquired with a repetition delay of 3 s, 
resulting in a total experimental time of 3 h. The delay in the 
echo blocks was  = 1.9 ms. The acquisition time in t2 was set 
to 15 ms, and t1
max = 10 ms. Exponential line broadening of 20 
Hz was applied in the direct and indirect dimensions prior to 
Fourier transform. 
 The 2D 1H-13C high-resolution HETCOR NMR spectra 
were recorded with a 4 mm triple resonance probe at 12.5 kHz 
MAS. The SPINAL-6445 sequence (1 = 100 kHz) was used 
for heteronuclear decoupling. The eDUMBO-122
47 sequence 
(1 = 100 kHz) was used for proton homonuclear decoupling 
in the indirect dimension. The 1H axis has been corrected for 
the experimentally determined homonuclear decoupling 
scaling factor using a value of 0.49. 178 increments of 48 
transients each were acquired for cocaine and 100 increments 
of 16 transients each were acquired for flufenamic acid, with 
an acquisition time in t2 of 27 ms, and a repetition delay of 20 
s, resulting in a total experimental time of 19 h for cocaine 
and 36 h for flufenamic acid. Exponential line broadenings of 
50 Hz were used in the direct and indirect dimensions. 
 The States-TPPI procedure was used for quadrature 
detection in the indirect dimension for all two-dimensional 
experiments. 
2c Crystal Structure Prediction 
Crystal structures were predicted by global lattice energy 
minimisation, starting from the chemical formulae of each of 
the molecules investigated here and without any structural 
hypothesis or any information obtained from the known 
crystal structure.  
 Theophylline was treated using a rigid molecular geometry 
throughout the calculations, using a B3LYP/6-31G(d,p) 
optimised molecular geometry. Crystal structures were 
generated with the CrystalPredictor program48, using quasi-
random sampling of unit cell dimensions, molecular positions and 
orientations within a set of the most commonly observed space 
groups, all with one molecule in the asymmetric unit (Z`=1). 
The resulting structures were initially lattice energy 
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minimised using an empirically parameterised exp-6 atom-
atom model of repulsion-dispersion interactions (the FIT 
potential described by Coombes et al.49) and electrostatic 
interactions modelled using atomic partial charges fitted to 
reproduce the molecular electrostatic potential. The resulting 
lowest energy crystal structures were re-optimised using the 
program DMACRYS50 using the same exp-6 model, but with 
electrostatics described using atomic multipoles, derived from 
a distributed multipole analysis51 of the B3LYP/6-31G(d,p) 
electron density.  
 For flufenamic acid and flutamide, we followed the 
protocol for crystal structure prediction (CSP) of flexible 
molecules outlined in reference 27 and further tested in 
references 52 and 18. A set of starting molecular conformations 
were selected as minima on the conformational energy surfaces 
of each molecule, which were sampled by systematically varying 
selected torsion angles: 6 starting conformations were selected for 
flufenamic acid and 8 for flutamide. Trial crystal structures 
were generated in common space groups with Z`=1 using the 
same method as for theophylline. These structures were 
further optimized (unit cell, molecular positions, and 
conformations) using a molecular mechanics description of 
inter- and intramolecular forces. Final energies of the lowest 
energy structures were calculated as a combination of a DFT 
(B3LYP/6-31G(d,p)) calculation for the intramolecular 
contribution and the exp-6 + atomic multipoles description for 
the intermolecular interactions. The influence of polarisation 
on the inter- and intra-molecular contributions to the relative 
crystal energies was approximated by performing the 
molecular calculations in a continuum dielectric ( = 3), as we 
have previously suggested for flexible molecule CSP53.  
 Due to the greater flexibility of the cocaine molecule, the 
CSP method was adapted to include an automated conformer 
search: conformations were generated using the low-mode 
search method54 and the all-atom optimized potentials for 
liquid simulations (OPLS-aa) force field55. The most stable 
resulting conformations were refined using constrained 
B3LYP/6-31G(d,p) geometry optimisations and 16 starting 
conformations were selected for crystal structure generation. 
Trial structures were generated in common Söhnke space 
groups with Z’=1 and the lowest energy structures were 
further optimised using CrystalOptimizer56, using a quantum 
mechanical description of the intramolecular forces and an 
atom-atom (exp-6 + atomic multipole electrostatics) 
description of the intermolecular forces. The final energy 
model was the same as that used for flufenamic acid and 
flutamide. Full details of the computational methods used for 
all four molecules are provided in the supplementary 
information. 
 To remove physically unrealistic structures, only the 
resulting structures within 8 - 10 kJ/mol of the lowest-energy 
structure for each molecule were retained for further analysis. 
Figure S12 shows the relative energies of the predicted 
structures within 8 - 10 kJ/mol of the minimum for all four 
molecules. CIF coordinate files for all low energy predicted 
structures are given in ESI. 
2d DFT Calculations 
Geometry optimizations and chemical shift calculations were 
carried out using the DFT program CASTEP57, which uses a 
planewave basis set, whose implicit translational symmetry is 
very well adapted to describing the wavefunctions of 
crystalline systems. The GIPAW method58, used with ultrasoft 
Vanderbilt-type pseudo-potentials59,60, provides an efficient 
method to calculate chemical shifts in crystalline solids61. 
 
 The geometry optimizations of the single crystal X-ray 
reference structures were carried out using the generalized 
gradient approximation (GGA) functional PBE62, a plane-
wave maximum energy cutoff energy of 700 eV, and a 
Monkhorst-Pack grid of k-points63 corresponding to a 
maximum spacing of 0.05 Å-1 in reciprocal space. During the 
geometry optimizations, the unit cell and all heavy atoms 
were fixed, and only the hydrogen positions were relaxed. 
 The chemical shieldings σcalc were calculated using the 
same functional and parameters as those used for the 
geometry optimization. They were then converted into 
calculated chemical shifts δcalc using the relation δcalc = σref 
σcalc with the value of σref determined for each molecule 
by a linear regression between calculated and experimental 
shifts, imposing a slope of unity. For the experimental 
chemical shifts that were not assigned, shifts and shielding 
were simply compared in order. Rotational dynamics were 
taken under consideration for the chemical shielding 
calculation for the methyl group protons in cocaine, flutamide 
and theophylline. They were averaged over the three protons 
to obtain a single calculated shielding value for each methyl 
group. Considering the fact that there is no indication from 
the NMR spectra of any large-scale dynamical processes, no 
other dynamic effects are considered for the chemical shift 
calculations. 
 CASTEP output files are given for all the structures in ESI. 
3. Results and discussion 
3a Assignment of experimental NMR spectra 
Several 1D and 2D NMR experiments are used to assign the 
1H and 13C resonances for each compound. The 1D 1H MAS 
and 13C CPMAS NMR spectra yield the 1H and 13C chemical 
shifts, which can then be assigned with the help of a 2D 
refocused INADEQUATE64 NMR experiment which provides 
the connectivities between directly connected carbons and a 
2D refocused INEPT46 NMR experiment to correlate the 
resonances of directly attached protons, thus providing the 
assignment for the corresponding proton resonances. 
 Figure 1 shows the 1H MAS NMR spectrum and the 13C 
CPMAS NMR spectrum of cocaine. The 1H and 13C chemical 
shifts can be assigned on the basis of an INEPT and an 
INADEQUATE experiment, for which portions of the spectra 
are shown in Fig. 2. The INADEQUATE NMR spectrum (Fig. 
2a) makes it possible to assign the carbons, but reveals two 
different possible assignments, and the INEPT NMR spectrum 
(Fig. 2b) reveals which peaks correspond to protons that are 
directly bonded to a carbon. Based on the 1H-13C correlations 
obtained from the INEPT NMR spectrum it becomes clear that 
only one of the two assignments obtained from the 
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INADEQUATE NMR experiment is feasible. The 1H and 13C 
chemical shifts obtained based on this assignment are 
summarized in Table 1. 
Fig. 1 (upper) 1H (500 MHz) MAS NMR spectrum of cocaine: recorded 
in 32 scans with a recycle delay of 8 s at 60 kHz MAS and (lower) 13C 
(125 MHz) CPMAS NMR spectrum. Both spectra were recorded with the 
bearing gas temperature regulated at 273 K. 
 
 
 
 
Fig. 2 (upper) The 13C-13C refocused INADEQUATE NMR spectrum and 
(lower) 1H-13C refocused INEPT NMR spectrum of cocaine.  The blue 
trace above the INEPT direct dimension is the 13C CPMAS NMR 
spectrum, while the stick plot to the left of the indirect dimension 
correspond to the 1H signals, as obtained from the INEPT correlations.  
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Table 1 Experimentally measured chemical shifts for cocaine. Labels are 
as given in Scheme 1-I. 
 
Atom label 13C Chemical shift 
(ppm) 
1H Chemical shift  
(ppm) 
1 65.95 3.76 
2 50.16 3.78 
3 66.70 5.63 
4 36.66 3.06 
5 62.63 3.32 
6 25.62 3.49 
7 25.62 3.38 
8 165.94 2.91 
9 129.37 2.56 
10 131.50 2.12 
11 133.50 8.01 
12 134.53 8.01 
13 133.50 8.01 
14 131.50 8.01 
15 172.18 8.01 
16 50.16 3.78 
17 41.52 3.78 
18 — 3.78 
19 — 1.04 
20 — 1.04 
21 — 1.04 
 
 Figure 3 shows the 1H MAS NMR spectrum and the 13C 
CPMAS NMR spectrum of flutamide. The 1H and 13C 
chemical shifts can be partially assigned on the basis of an 
INEPT and an INADEQUATE experiment, for which portions 
of the spectra are shown in Fig. 4. In the aromatic region, the 
INEPT NMR spectrum reveals which peaks correspond to 
carbons that are directly bonded to a hydrogen, and the 
INADEQUATE NMR spectrum makes it possible to identify a 
circular chain of carbons. When these two pieces of 
information are combined, two assignments are possible for 
the aromatic carbons, and correspondingly for the protons 
bonded to an aromatic carbon. The assignment of the two 
methyl groups is also ambiguous. The possible assignments 
are summarized in Table 2. For the comparison with the 
calculated chemical shifts, both assignments were taken under 
consideration and the assignment with the lowest rmsd is 
shown in the rmsd plots (Section 3c). 
 
Fig. 3 (upper) 1H (500 MHz) MAS NMR spectrum of flutamide: recorded 
in 8 scans with a recycle delay of 30 s at 60 kHz MAS and (lower) 13C 
(125 MHz) CPMAS NMR spectrum. Both spectra were recorded with the 
bearing gas temperature regulated at 293 K. The two possible assignments 
for 1H and 13C are indicated in red and blue. 
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Fig. 4 (upper) Extracts from the aromatic region of the 13C-13C refocused 
INADEQUATE NMR spectrum and (lower) 1H-13C refocused INEPT 
NMR spectrum of flutamide. The two possible assignments for 1H and 
13C are indicated in red and blue. 
 
Table 2 Experimentally measured chemical shifts for flutamide. The two 
assignments compatible with the experimental NMR data are shown in 
the left and right columns for each nucleus. Labels are as given in Scheme 
1-II. The possible permutations of the assignments are discussed in the 
text. 
Atom label 13C Chemical shift 
(ppm) 
1H Chemical shift  
(ppm) 
1 140.9 or 145.4 — 
2 124.4 — 
3 116.7 or 130.9 7.1 or 8.0 
4 145.4 or 140.9 — 
5 124.4 9.9 
6 130.9 or 116.7 8.0 or 7.1 
7 ~122 — 
8 — 8.0 
9 176.1 — 
10 35.9 2.0 
11 17.8 or 21.8 1.2 
12 21.8 or 17.8 1.2 
 
 Figure 5 shows the 1H MAS NMR spectrum and the 13C 
CPMAS NMR spectrum of flufenamic acid. Due to a very 
long 1H longitudinal relaxation time, it was not possible to 
record an INADEQUATE NMR spectrum to obtain the 13C-
13C correlations. As a result, the carbon-13 chemical shifts 
were assigned by comparison with the assigned 13C shifts 
measured in a solution of CDCl3 (Figure S19). Using this 
traditional method, and the identification of quaternary 
carbons from the 2D 1H-13C HETCOR NMR spectrum (Figure 
6), we could clearly assign all except the C4, C13 and C11 
peaks which are sufficiently close in the two spectra as to be 
ambiguous. The 1H chemical shifts were then assigned based 
on the 1H-13C connectivities obtained from the HETCOR 
NMR spectrum. The assignments of the experimental peaks 
obtained in this way for 1H and 13C are shown in Table 3. 
Note that, in practice, a long T1 is indeed a key problem for 
assignments at natural abundance for compounds of unknown 
structure. Recently introduced impregnation DNP approaches 
may alleviate this issue in the future65. 
 
 
Fig. 5 (upper) 1H (500 MHz) MAS NMR spectrum of flufenamic acid and 
(lower) 13C (125 MHz) CPMAS NMR spectrum. 
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Fig. 6 Aromatic part of the 1H-13C HETCOR NMR spectrum of 
flufenamic acid.  The trace above the direct dimension corresponds to the 
13C CPMAS NMR spectrum. 
 
Table 3 Experimentally measured chemical shifts for flufenamic acid. 
Here the assignments are made based on the comparison between 
experimental and calculated chemical shifts using the flufenamic acid 
crystal structure obtained from the literature. Labels are as given in 
Scheme 1-III. 
Atom label 13C Chemical shift 
(ppm) 
1H Chemical shift  
(ppm) 
1 149.3 — 
2 109.7 — 
3 133 8.3 
4 117.2, 121.7 or 119.8 6.0, 6.9, or 6.2 
5 136.3 5.4 
6 112 6.8 
7 175 — 
8 — 9.6 
9 — 12.4 
10 139.9 — 
11 121.7, 119.8 or 117.2, 6.9, 6.2 or 6.0 
12 131.7 — 
13 119.8, 117.2 or 121.7  6.2, 6.0 or 6.9 
14 129.5 5.9 
15 128.1 7.3 
16 124.1 — 
 
 Figure 7 shows the 1H MAS NMR spectrum and the 13C 
CPMAS NMR spectrum for theophylline. The 1H NMR 
spectrum of theophylline consists of only three resonance 
frequencies, the assignment of which is unambiguous. A 
tentative assignment of the 13C NMR spectrum, based on 
solution-state NMR data, can be found in the literature66. 
However, no attempt was made to directly determine the 
assignment here, as this information was not helpful in the 
case of theophylline for the method studied here, as will be 
discussed below. 
 
 
 
 
Fig. 7 (upper) 1H (500 MHz) MAS NMR spectrum of theophylline and 
(lower) 13C (125 MHz) CPMAS NMR spectrum. 
 
Table 4 Proposed chemical shift assignments for theophylline. Labels are 
as given in Scheme 1-IV. 
Atom label 13C Chemical shift 
(ppm) 
1H Chemical shift  
(ppm) 
1 150.8 — 
2 146.1 — 
3 105.8 — 
4 155.0 — 
5 140.8 7.7 
6 29.9 3.4 
7 29.9 3.4 
8 — 14.6 
 
3b Cocaine Structure Selection 
Figure 8 shows the 1H rms deviations between experimental 
and calculated chemical shifts for the set of the 30 lowest 
energy predicted crystal structures of cocaine (all structures 
are within 10 kJ mol-1 of the global lattice energy minimum). 
Importantly, as observed previously for thymol38, the 
agreement between calculated and experimental chemical 
shifts is not correlated with the predicted energy (structures 
are ordered by ascending predicted energy). Thus, 
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experimental isotropic chemical shifts contain information 
complementary to that which is contained in the energy 
models used in the CSP protocol. Based on the agreement 
between calculated and experimental chemical shifts, we can 
determine structure 1 to be the correct crystal structure of the 
sample used in the present study. This is validated when 
comparing the calculated chemical shifts for the previously 
known reference single crystal X-ray structure with the 
experimentally recorded chemical shifts, as observed in Fig. 
8. Note that to estimate the uncertainty in the calculated values, 
chemical shift calculations for 15 organic compounds (X-ray 
structures with CASTEP optimized hydrogen positions) were 
carried out, finding a mean rms error of 0.33 ppm (±0.16 ppm) 
from the experimental values for 1H and 1.9 ppm (±0.4 ppm) for 
13C38. These mean errors are indicated as a dotted horizontal line 
in Figure 8 for 1H and Figures S1-S2 for 13C, for example, with 
the limits indicated by the grey zones in the figures. Differences 
smaller than these average values can thus be considered 
insignificant here. Furthermore, we should not be concerned that 
predicted structures lead to chemical shift rmsd values which lie 
just outside the expected range, as small structural deviations 
could lead to larger differences between chemical shifts 
calculated from predicted structures than from experimentally 
determined structures. 
Fig. 8 Comparison between experimental and calculated 1H chemical 
shifts for cocaine. The comparison is made using assigned experimental 
chemical shifts. Predicted structures are ordered by increasing calculated 
lattice energies (decreasing predicted stability). The comparison with the 
crystal structure determined from single crystal XRD is shown on the far 
right. The dotted horizontal black line shows the mean rmsd error as 
described in the main text and the horizontal grey shaded zone indicates 
the expected limits of the rmsd in chemical shift. 
 
 
Fig. 9 Comparison between the structure of cocaine free base determined 
by powder 1H NMR and computational modelling here and the single 
crystal XRD determined structure. 
 
 The all-atom rmsd between the molecular geometry of the 
structure determined here and the previously known structure 
of cocaine (CSD entry code: COCAIN10) is found to be 0.069 
Å, and Figure 9 shows the two structures superimposed. The 
unit cell dimensions all agree to within 2.3% and the volume 
difference between the two structures is 0.8% (3.29 Å3 per 
molecule). 
 
3c Flutamide Structure Selection 
Figure 10 shows the 1H rmsds between experimental and 
calculated chemical shifts for the set of the 21 lowest energy 
predicted crystal structures of flutamide (all structures within 
10 kJ mol-1 of the global lattice energy minimum).  
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Fig. 10 Comparison between experimental and calculated 1H chemical 
shifts for flutamide. The comparison is made using assigned experimental 
chemical shifts. Predicted structures are ordered by increasing calculated 
lattice energies (decreasing predicted stability). The display parameters 
are as for Figure 8. For the rmsd calculation, both experimental 
assignments were taken into account and the assignment that gave the 
smallest rmsds is presented in the Figure. 
 
 For flutamide, the 1H rmsds were first calculated by 
assuming that the experimental chemical shifts were not 
assigned. For such a comparison, the experimental and 
calculated chemical shifts are simply ordered by increasing 
value. This case is presented in Fig. S3 (see ESI). The rms 
deviation does not provide a sufficient criterion to 
unambiguously select a computationally generated structure 
since many predicted structures result in similar rms 
deviations. When the assignment of the experimental 1H 
chemical shifts is taken into account (Fig. 10), the rms 
deviations change significantly for some predicted structures, 
with structures that had low rms deviations of unassigned 
chemical shifts having much larger rmsds once assigned, and 
therefore are no longer compatible with the NMR data to 
within the estimated tolerances.  
 However, we note that even with the (ambiguous) 
assignment there are four predicted structures that are in good 
agreement with the unassigned experimental 13C shifts (Figure 
S3). In contrast, we note that the relative variation in the 
proton shifts is much larger, and only one structure (ranked 
number 5 by lattice energy) is in good agreement. Structure 5 
is thus selected here for the powder sample. The structure 
found here agrees with the structure of flutamide previously 
determined by single crystal XRD40 as shown in Figure 11. 
There is a 0.097Å all-atom rmsd between the molecular 
geometries in the structure determined here and the reference 
structure. The unit cell lengths are all in agreement to within 
1.55% or better, and the volume agrees to within 0.6% (1.71 
Å3 per molecule).  
 Note that this result contrasts with the case of thymol38, for 
which unassigned 1H chemical shifts were sufficient to 
determine the correct structure. For flutamide, the 13C 
chemical shifts do not identify the correct structure and 
assigned 1H chemical shifts are required to rule out several of 
the higher energy predicted structures (see Figure S3 for a 
rmsd plot using unassigned 1H shifts). Here, the significant 
change in the rms deviation for assigned and unassigned 1H 
chemical shifts is due in particular to the large variability of 
the intermolecular contributions to the chemical shifts for the 
aromatic protons of flutamide. The peak-by-peak comparison 
of calculated shifts for the structure determined here and the 
measured values is shown in Figure S10. 
 
 
Fig. 11 Comparison between the structure of flutamide determined by 
powder 1H NMR and computational modelling here and the reference 
single crystal XRD determined structure. 
 
3d Flufenamic acid Structure Selection 
Figure 12 shows the rmsds between the assigned experimental 
and calculated 1H chemical shifts for the set of the 50 lowest 
energy predicted structures of flufenamic acid (spanning just 
over 8 kJ mol-1 from the global lattice energy minimum). 
Here, unassigned shifts are again insufficient to identify the 
correct crystal structure (Figure S5) and it is seen even more 
clearly than for flutamide that neither unassigned or assigned 
13C shifts discriminate strongly (Figures S5 and S6); in fact, 
all of the structures lead to calculated 13C chemical shifts that 
are in poor agreement with the data. This is probably because 
of the relatively limited range in chemical shifts covered by 
the carbon-13 NMR spectrum.  
 In contrast, we again see that the assigned 1H shifts provide 
a much stronger discrimination (Figure 12). In this case only 
four structures are in agreement to within our estimated 
tolerances, with structure 2 giving by far the best agreement.  
 Note that the 1H rmsd comparison shown in Figure 12 
excludes the OH and NH chemical shifts since these two 
shifts show considerable temperature dependence (Figure 
S20). Including these peaks for the rmsd calculation 
introduces errors due to the fact that the experiments are 
recorded at 293 K, while DFT calculations are temperature-
 This journal is © The Royal Society of Chemistry [year] Journal Name, [year], [vol], 00–00  |  10 
free (temperature only enters predicted crystal structures via 
the empirical parameterisation of the interatomic model 
potential). However, even when using all the 1H chemical 
shifts for the comparison, predicted structure 2 remains in 
very good relative agreement with the observed 1H chemical 
shifts (Fig. S7), albeit with an overall higher rmsd than in the 
case where the NH and OH shifts are not used. The peak-by-
peak comparison of calculated shifts for the structure 
determined here and the measured values is shown in Figure 
S11. 
 The all-atom rmsd between the molecular geometry in 
structure number 2 determined here for the powder with the 
reference structure of flufenamic acid (CSD entry code: 
FPAMCA11) is found to be 0.117 Å, and Figure 13 shows the 
two structures superimposed. The unit cell dimensions all 
agree to within 5% and the volume difference between the two 
structures is 1.4% (4.58 Å3 per molecule). 
 
Fig. 12 Comparison between assigned experimental and calculated 
chemical shifts for flufenamic acid for 1H (excluding the OH and NH 
chemical shifts). Predicted structures are ordered by decreasing stability. 
The display parameters are as for Figures 8 and 10. 
 
 
Fig. 13 Comparison between the reference P21/c crystal structure of 
flufenamic acid and the structure determined here. 
3e Theophylline Structure Selection 
Figure 14 shows the rmsds between the experimental and 
calculated 1H chemical shifts for a set of the 44 lowest energy 
predicted structures of theophylline (all structures are within 
10 kJ mol-1 of the global lattice energy minimum). In this 
case, the results remain unchanged when unassigned instead 
of assigned chemical shifts are used (see Figure S8 in the 
supplementary information). 
 
Fig. 14 Comparison between 1H experimental and calculated chemical 
shifts for theophylline. Predicted structures are ordered by decreasing 
stability. The display parameters are as for Figures 8, 10, and 12. 
Structures marked with * contain N-H…O hydrogen bonding. 
  
 For 13C chemical shifts, again the agreement between 
calculated and experimental chemical shifts (regardless if they 
are assigned or unassigned) does not vary significantly from 
one predicted structure to another as can be seen in Figures S8 
and S9. However, in this case, the same is true for the 1H 
chemical shifts: although some structures lead to a large rms 
deviation from observed values, there are many structures that 
produce comparable values in agreement with the observed 
data. In this case, while structure 1 (the global minimum in 
lattice energy) corresponds to the known crystal structure of 
the theophylline polymorph under investigation, neither set of 
chemical shifts is sufficient to identify this structure from the 
list of predictions. This observation is not surprising, given 
the fact that the 1H NMR spectrum of theophylline (Figure 7) 
consists of only three peaks, and illustrates one of the limits 
of the method.  
 Despite providing insufficient information to distinguish 
between many of the predicted structures of theophylline, we 
do observe that the 1H chemical shifts correctly determine the 
hydrogen bonding topology in the theophylline polymorph 
studied here: all predicted structures with rms deviations of 
1H chemical shifts within our expected tolerances display 
hydrogen bonding of the NH to the nitrogen atom in the five-
membered ring. In contrast, all predicted structures in which 
one of the oxygen atoms acts as the hydrogen bond acceptor 
lead to very high deviations in chemical shifts; these 
structures are labelled in Figure 14. The ability to distinguish 
between possible hydrogen bonding patterns is important for 
theophylline, whose polymorphs differ in which hydrogen 
bond acceptors are used67,68. 
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4. Conclusion 
We have further investigated a protocol for natural abundance 
powder NMR crystallography, based on combining theoretical 
crystal structure prediction with experimental solid-state 
NMR measurements and density functional theory 
calculations of NMR chemical shifts. The method has been 
applied to four powdered pharmaceutical compounds: 
cocaine, flutamide, theophylline and flufenamic acid.  
 The study reveals two features of the method. Firstly, we 
find that for both flutamide and flufenamic acid that the 1H 
NMR spectra need to be at least partially assigned for the 
method to be robust, although the method has been proven to 
be successful without assignment for the previous case of 
thymol, and for cocaine. The partial requirement for 
assignment is not surprising since given chemical shifts can 
vary between one predicted crystal structure and another, 
leading to changes in the order of the peaks in the spectrum. 
This can make an unassigned comparison less sensitive, i.e. an 
incorrect structure can yield matching chemical shifts. 
Secondly, and this is possibly the most interesting feature of 
this study, we confirm that proton chemical shifts are more 
sensitive than carbon shifts to structural changes. For cocaine, 
flutamide, and flufenamic acid, we find that proton chemical 
shifts lead to a clear structure determination by comparison 
with the ensemble of structure predictions, whereas in all 
these cases the carbon-13 chemical shifts are not sufficiently 
sensitive to lead to structure determination. This observation 
suggests that proton NMR will play an increasingly important 
role in NMR crystallography.  
 We believe that the method is robust, but currently some 
precautions do need to be taken. For example, spectra should 
be recorded as a function of temperature to determine if there 
are any peaks (often involved in H-bonding, for example) that 
vary significantly with temperature. Since the DFT chemical 
shift calculations do not currently take temperature into 
account, such peaks may need to be excluded from the 
analysis (as was the case here for the NH and OH protons of 
flufenamic acid). Alternatively, temperature should be 
included in the crystal structure prediction calculations, by 
optimising structures on the free energy surface in place of the 
lattice energy minimisation. 
 Finally, we note that the method did not succeed for 
theophylline, since the NMR data are too sparse to be strongly 
discriminant, though we could identify the correct H-bonding 
pattern. We do note that a method based on combining DFT 
calculations with powder XRD and 13C and 15N solid-state 
NMR has been previously reported to successfully identify the 
correct polymorph of theophylline.69 In general it is likely that 
the combination of the NMR methods here with powder XRD 
will always improve the quality of the procedure (though the 
objective of the present work was to evaluate the performance 
of a method which uses the NMR chemical shifts in isolation). 
 We note in conclusion that the powders studied here were 
not subjected to any modification prior to the experiments, 
and that they were investigated at natural isotopic abundance. 
The method should be of widespread interest in many areas, 
and particularly in pharmaceutical materials science. The 
accurate prediction of the cocaine crystal structure included 
here demonstrates recent advances that have been made in 
CSP methodologies for large, flexible molecules and, as 
developments continue, the structure prediction 
methodologies could lead to solving the crystal structure of 
organic molecules up to 1000 g/mol or larger. This would 
cover most pharmaceutically relevant systems, and could also 
open up the possibility of predicting more complex materials 
such as hybrid organic-inorganic materials. 
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